SCHEMBL4634025

SCHEMBL4634025

O=C(O)COc1cccc2sc3ccccc3c(=O)c12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.54
ALDH1A1 P00352 3/20 0.54
KDM4E B2RXH2 2/20 0.54
TDP1 Q9NUW8 2/20 0.54
PTPN1 P18031 5/20 0.48
PTPN2 P17706 1/20 0.48
MAPT P10636 2/20 0.47
NPC1 O15118 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
RAB9A P51151 1/20 0.47
L3MBTL1 Q9Y468 2/20 0.45
POLB P06746 2/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
GLA P06280 1/20 0.45
ALOX15 P16050 1/20 0.44
MAOA P21397 1/20 0.43
MAOB P27338 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29897738 1.00 HPGD (0.54) HPGDALDH1A1KDM4ETDP1PTPN1
SCHEMBL15549093 0.86 LMNA (0.48) HPGDALDH1A1KDM4ETDP1PTPN1
SCHEMBL8411604 0.83 PTPN1 (0.54) HPGDALDH1A1KDM4ETDP1PTPN1
SCHEMBL7923749 0.82 NPC1 (0.48) HPGDALDH1A1TDP1MAPTNPC1
SCHEMBL28669651 0.82 F9 (0.49) HPGDTDP1MAPTNPC1CYP1A2
SCHEMBL3252488 0.81 MAPT (0.54) HPGDALDH1A1KDM4ETDP1MAPT
SCHEMBL7098554 0.81 MAPT (0.50) HPGDALDH1A1KDM4ETDP1MAPT
SCHEMBL6483685 0.81 HPGD (0.51) HPGDALDH1A1KDM4ETDP1PTPN1
SCHEMBL24948345 0.80 MAPT (0.44) HPGDALDH1A1TDP1MAPTNPC1
SCHEMBL8096279 0.80 MAPT (0.51) HPGDALDH1A1KDM4ETDP1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 175 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12516203-B2 Ink composition DOMINO PRINTING SCIENCES PLC (GB) 2026-01-06 US claimed
EP-3911709-B1 INK COMPOSITIONS DOMINO PRINTING SCIENCES PLC (GB) 2023-11-15 EP claimed
CN-109071976-B Radiation curable ink formulations 富林特集团瑞典有限公司 2022-06-03 CN claimed
EP-3445826-B1 RADIATION CURABLE INK FORMULATION FLINT GROUP GERMANY GMBH (DE) 2021-07-14 EP claimed
US-20190106583-A1 RADIATION CURABLE INK FORMULATION FLINT GROUP SWEDEN AB (SE) 2019-04-11 US claimed
EP-3420039-A1 PRINTING FORMULATIONS AND METHODS Velox-Puredigital Ltd. (IL) 2019-01-02 EP claimed
CN-109071977-A PRINTING FORMULATIONS AND METHODS 维罗斯-纯粹数字有限公司 2018-12-21 CN claimed
CN-109071976-A Radiation curable ink preparation 富林特集团德国有限公司 2018-12-21 CN claimed
WO-2017182638-A1 RADIATION CURABLE INK FORMULATION FLINT GROUP GERMANY GMBH (DE) 2017-10-26 WO claimed
EP-2812403-B1 UV CURABLE METALLIC DECORATIVE COMPOSITIONS ACTEGA NORTH AMERICA INC (US) 2017-09-06 EP claimed
WO-2017145159-A1 PRINTING FORMULATIONS AND METHODS VELOX-PUREDIGITAL LTD. (IL) 2017-08-31 WO claimed
CN-104603212-B The curable metal finishing compositions of UV 阿塔卡北美公司 2017-07-07 CN claimed
US-9617445-B2 UV curable metallic decorative compositions ACTEGA NORTH AMERICA, INC. (US) 2017-04-11 US claimed
US-20150344722-A1 UV CURABLE METALLIC DECORATIVE COMPOSITIONS ACTEGA NORTH AMERICA, INC. 2015-12-03 US claimed
CN-104603212-A Uv curable metallic decorative compositions ACTEGA KEL STAR INC 2015-05-06 CN claimed
EP-2812403-A1 UV CURABLE METALLIC DECORATIVE COMPOSITIONS Actega Kelstar, Inc. (US) 2014-12-17 EP claimed
WO-2013119387-A1 UV CURABLE METALLIC DECORATIVE COMPOSITIONS HENKEL CORPORATION (US) 2013-08-15 WO claimed
US-12590212-B2 Method of improving actinic cure of energy curable inks and coatings SUN CHEMICAL CORPORATION (US) 2026-03-31 US disclosed
WO-2003072567-A1 NOVEL FUSED RING COMPOUNDS, AND THEIR USE AS CATIONIC PHOTOINITIATORS SUN CHEMICAL CORPORATION (US) 2003-09-04 WO disclosed
WO-2003072568-A1 THIOXANTHONE DERIVATIVES, AND THEIR USE AS CATIONIC PHOTOINITIATORS SUN CHEMICAL CORPORATION (US) 2003-09-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12590212-B2 Method of improving actinic cure of energy curable inks and coatings ACTB, ACTN1, CFL1 HPGD 2846/4885ALDH1A1 1431/4885KDM4E 1144/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.